Overview

Alzheimer's Disease Long-term Follow-up Study (ALF Study)

Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
Open study for efficacy and safety of donepezil treatment during 48 weeks
Phase:
Phase 4
Details
Lead Sponsor:
Eisai Korea Inc.
Treatments:
Donepezil